Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 20:46 |
CROSSJECT lève 5 millions d'euros auprès de Vatel Capital
|
French | 193.4 KB | ||
| 2025-11-14 20:46 |
CROSSJECT completes €5 million financing with Vatel Capital
|
English | 192.9 KB | ||
| 2025-11-06 17:30 |
CROSSJECT : Information relative au nombre total de droits de vote et d'actions…
|
French | 128.1 KB | ||
| 2025-10-30 20:00 |
CROSSJECT annonce la mise à disposition du rapport financier semestriel au 30 j…
|
French | 82.1 KB | ||
| 2025-10-29 17:30 |
CROSSJECT : Information relative au nombre total de droits de vote et d'actions…
|
French | 152.7 KB | ||
| 2025-10-29 17:30 |
CROSSJECT : Information relative au nombre total de droits de vote et d'actions…
|
French | 152.7 KB | ||
| 2025-09-24 22:00 |
CROSSJECT présente ses résultats financiers et les principaux faits marquants p…
|
French | 200.2 KB | ||
| 2025-09-24 22:00 |
CROSSJECT presents its financial results and key highlights for the first half …
|
English | 199.6 KB | ||
| 2025-09-22 07:30 |
CROSSJECT obtient un financement supplémentaire de la BARDA pour soutenir le dé…
|
French | 89.8 KB | ||
| 2025-09-22 07:30 |
CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental an…
|
English | 117.2 KB | ||
| 2025-08-27 17:30 |
CROSSJECT : Information relative au nombre total de droits de vote et d'actions…
|
French | 132.7 KB | ||
| 2025-08-27 17:30 |
CROSSJECT : Information relative au nombre total de droits de vote et d'actions…
|
French | 132.1 KB | ||
| 2025-08-04 17:35 |
CROSSJECT reste mobilisé pendant la coupure estivale
|
French | 387.7 KB | ||
| 2025-08-04 17:35 |
CROSSJECT remains engaged during the summer break
|
English | 374.9 KB | ||
| 2025-07-08 17:30 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2025
|
French | 116.1 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
